Europe Precision Oncology Market

Europe Precision Oncology Market size was valued at USD 28.4 billion in 2025 and is forecast to grow from USD 31.2 billion in 2026 to reach USD 50.7 billion by 2031, at a CAGR of 12.3%.

Description

The Europe Precision Oncology Market size was valued at USD 28.4 billion in 2025 and is forecast to grow from USD 31.2 billion in 2026 to reach USD 50.7 billion by 2031, at a CAGR of 12.3%. Precision oncology encompasses targeted therapies, immunotherapies, hormonal therapies, and companion diagnostics used to identify molecular and genetic markers that guide cancer treatment decisions, ranging from biomarker-based drug therapies to advanced genomic profiling performed in specialty cancer centers and research institutes. The market sits at the intersection of oncology, genomics, and personalized medicine, making it one of the most rapidly advancing enabling categories across the regional healthcare and life sciences value chain.

Demand for precision oncology products remains anchored by rising cancer incidence rates, growing adoption of biomarker-guided treatment protocols, and expanding use of next-generation sequencing across Germany, France, the United Kingdom, and Italy. Beyond targeted therapy, precision oncology continues to enable applications in immuno-oncology, companion diagnostics, and liquid biopsy that require accurate, personalized treatment solutions. Increasing reimbursement coverage, expanding clinical trial activity, and continued genomic research investment are sustaining consumption even as the region transitions toward more integrated, data-driven cancer care models.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Precision Oncology Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Therapy Type (Targeted Therapy, Immunotherapy, Hormonal Therapy, Chemotherapy, Others)

      2. By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)

      3. By End User (Home Care Settings, Hospitals & Specialty Cancer Centers, Diagnostic Laboratories, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Precision Oncology Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Therapy Type

      2. By Cancer Type

      3. By End User

      4. By Region

  • France Precision Oncology Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Therapy Type

      2. By Cancer Type

      3. By End User

      4. By Region

  • United Kingdom Precision Oncology Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Therapy Type

      2. By Cancer Type

      3. By End User

      4. By Region

  • Italy Precision Oncology Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Therapy Type

      2. By Cancer Type

      3. By End User

      4. By Region

  • Spain Precision Oncology Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Therapy Type

      2. By Cancer Type

      3. By End User

      4. By Region

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Precision Oncology Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Roche Holding AG

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Novartis AG

    3. AstraZeneca PLC

    4. Bristol-Myers Squibb Company

    5. Merck KGaA

    6. Pfizer Inc.

    7. Eli Lilly and Company

    8. Bayer AG

    9. Sanofi S.A.

    10. Amgen Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology